BlackRock’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $211K | Buy |
23,667
+1,597
| +7% | +$15.9K | ﹤0.01% | 4753 |
|
|
2025
Q4 | $184K | Sell |
22,070
-145
| -0.7% | -$1.46K | ﹤0.01% | 4744 |
|
|
2025
Q3 | $267K | Sell |
22,215
-156
| -0.7% | -$1.91K | ﹤0.01% | 4621 |
|
|
2025
Q2 | $190K | Buy |
22,371
+198
| +0.9% | +$2.02K | ﹤0.01% | 4683 |
|
|
2025
Q1 | $251K | Sell |
22,173
-3,267
| -13% | -$59.3K | ﹤0.01% | 4558 |
|
|
2024
Q4 | $519K | Buy |
25,440
+3,171
| +14% | +$92.5K | ﹤0.01% | 4404 |
|
|
2024
Q3 | $884K | Buy |
22,269
+397
| +2% | +$10.7K | ﹤0.01% | 4205 |
|
|
2024
Q2 | $385K | Buy |
21,872
+4,123
| +23% | +$69.8K | ﹤0.01% | 4410 |
|
|
2024
Q1 | $295K | Sell |
17,749
-71
| -0.4% | -$1.03K | ﹤0.01% | 4507 |
|
|
2023
Q4 | $337K | Sell |
17,820
-36
| -0.2% | -$676 | ﹤0.01% | 4522 |
|
|
2023
Q3 | $371K | Buy |
17,856
+5,940
| +50% | +$180K | ﹤0.01% | 4504 |
|
|
2023
Q2 | $651K | Buy |
11,916
+3,160
| +36% | +$97.2K | ﹤0.01% | 4412 |
|
|
2023
Q1 | $158K | Sell |
8,756
-14
| -0.2% | -$241 | ﹤0.01% | 4840 |
|
|
2022
Q4 | $89K | Sell |
8,770
-19
| -0.2% | -$203 | ﹤0.01% | 5079 |
|
|
2022
Q3 | $116K | Sell |
8,789
-28
| -0.3% | -$424 | ﹤0.01% | 5134 |
|
|
2022
Q2 | $113K | Buy |
8,817
+82
| +0.9% | +$2.17K | ﹤0.01% | 5206 |
|
|
2022
Q1 | $453K | Buy |
8,735
+9
| +0.1% | +$381 | ﹤0.01% | 4901 |
|
|
2021
Q4 | $394K | Buy |
8,726
+67
| +0.8% | +$3.59K | ﹤0.01% | 4941 |
|
|
2021
Q3 | $568K | Buy |
8,659
+21
| +0.2% | +$1.59K | ﹤0.01% | 4722 |
|
|
2021
Q2 | $865K | Sell |
8,638
-35,997
| -81% | -$3.71M | ﹤0.01% | 4559 |
|
|
2021
Q1 | $5.7M | Buy |
44,635
+1,081
| +2% | +$160K | ﹤0.01% | 3881 |
|
|
2020
Q4 | $4.84M | Buy |
43,554
+2,434
| +6% | +$273K | ﹤0.01% | 3726 |
|
|
2020
Q3 | $4.84M | Sell |
41,120
-728
| -2% | -$126K | ﹤0.01% | 3585 |
|
|
2020
Q2 | $8.98M | Buy |
41,848
+3,167
| +8% | +$748K | ﹤0.01% | 3244 |
|
|
2020
Q1 | $8.72M | Buy |
38,681
+551
| +1% | +$157K | ﹤0.01% | 3072 |
|
|
2019
Q4 | $10.2M | Buy |
38,130
+3,418
| +10% | +$859K | ﹤0.01% | 3240 |
|
|
2019
Q3 | $10.5M | Buy |
34,712
+1,445
| +4% | +$444K | ﹤0.01% | 3185 |
|
|
2019
Q2 | $11M | Buy |
33,267
+3,666
| +12% | +$1.86M | ﹤0.01% | 3195 |
|
|
2019
Q1 | $18.5M | Buy |
29,601
+209
| +0.7% | +$95.3K | ﹤0.01% | 2780 |
|
|
2018
Q4 | $7.31M | Buy |
29,392
+108
| +0.4% | +$43K | ﹤0.01% | 3236 |
|
|
2018
Q3 | $13.6M | Buy |
29,284
+230
| +0.8% | +$111K | ﹤0.01% | 3079 |
|
|
2018
Q2 | $15.8M | Buy |
29,054
+1,340
| +5% | +$804K | ﹤0.01% | 2993 |
|
|
2018
Q1 | $15.9M | Sell |
27,714
-4
| -0% | -$2.52K | ﹤0.01% | 2891 |
|
|
2017
Q4 | $17.7M | Buy |
27,718
+217
| +0.8% | +$153K | ﹤0.01% | 2845 |
|
|
2017
Q3 | $25.9M | Buy |
27,501
+142
| +0.5% | +$109K | ﹤0.01% | 2655 |
|
|
2017
Q2 | $23.9M | Sell |
27,359
-165
| -0.6% | -$135K | ﹤0.01% | 2692 |
|
|
2017
Q1 | $19M | Buy |
27,524
+27,480
| +62,455% | +$18.1M | ﹤0.01% | 2790 |
|
|
2016
Q4 | $32K | Sell |
44
-7
| -14% | -$4.84K | ﹤0.01% | 3113 |
|
|
2016
Q3 | $38K | Buy |
51
+3
| +6% | +$2.43K | ﹤0.01% | 3091 |
|
|
2016
Q2 | $40K | Buy |
48
+22
| +85% | +$20.5K | ﹤0.01% | 3038 |
|
|
2016
Q1 | $22K | Buy |
26
+17
| +189% | +$13.4K | ﹤0.01% | 2811 |
|
|
2015
Q4 | $11K | Hold |
9
| – | – | ﹤0.01% | 2855 |
|
|
2015
Q3 | $8K | Hold |
9
| – | – | ﹤0.01% | 2840 |
|
|
2015
Q2 | $17K | Sell |
9
-2
| -18% | -$2.54K | ﹤0.01% | 2479 |
|
|
2015
Q1 | $13K | Hold |
11
| – | – | ﹤0.01% | 2591 |
|
|
2014
Q4 | $12K | Buy |
11
+2
| +22% | +$2.05K | ﹤0.01% | 2661 |
|
|
2014
Q3 | $9K | Hold |
9
| – | – | ﹤0.01% | 2801 |
|
|
2014
Q2 | $12K | Hold |
9
| – | – | ﹤0.01% | 2667 |
|
|
2014
Q1 | $12K | Hold |
9
| – | – | ﹤0.01% | 2619 |
|
|
2013
Q4 | $10K | Hold |
9
| – | – | ﹤0.01% | 2721 |
|
|
2013
Q3 | $11K | Buy |
+9
| New | +$6.11K | ﹤0.01% | 2587 |
|
Other funds holding RMTI
VCM
VFT
WANY
BlackRock's RMTI Position: Q1 2026 in Review
BlackRock increased its Rockwell Medical (RMTI) stake by 7.2% in Q1 2026, buying an estimated $15.9K and bringing the position to 23,667 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #4753.
BlackRock first reported a position in RMTI in Q3 2013 and has held it in 51 quarters since. The position peaked at $25.9M in Q3 2017. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- BlackRock held 23,667 shares of Rockwell Medical worth $211K as of Q1 2026.
- BlackRock bought 1,597 Rockwell Medical shares in Q1 2026, an estimated $15.9K.
- Rockwell Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4753 holding.
- BlackRock first reported a position in Rockwell Medical in Q3 2013 and has held it in 51 quarters since.
- BlackRock's Rockwell Medical position peaked at $25.9M in Q3 2017.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.